Evaluate the Safety, Tolerability of BAT6026

NCT06094179 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

33

Enrollment

INDUSTRY

Sponsor class

Conditions

Dermatitis, Atopic

Interventions

DRUG: Monoclonal antibody BAT6026
DRUG: sodium chloride injection

Sponsor

Bio-Thera Solutions